Antibody Drug Conjugate Assessment and Therapeutics Review 2018

Report Description
This report analyzes the antibody drug conjugate market by type (Polyvalent, Monovalent, Others), by Species (Snake, Others), by Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Others), by Products (Snake Antibody drug conjugate, Others) and region; it also studies the top manufacturers in the market.
During the forecast period, 2017–2023 the global market of antibody drug conjugate is predicted to grow at a CAGR of 19% roughly.
 
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3365852-antibody-drug-conjugate-market-research-report-forecast-to-2023
 
The major players in antibody drug conjugate market include:
•             Seattle Genetics (US)
•             ImmunoGen, Inc. (US)
•             Roche Holding AG (Switzerland)
•             Genentech (US)
•             Concortis Biotherapeutics (US)
•             Agensys, Inc. (US)
•             Antikor (UK)
•             Immunomedics (US)
•             Pfizer Inc. (US)
•             Celldex Therapeutics (US)
•             Millennium Pharmaceuticals (US)
•             AbbVie Inc. (US)
•             Bayer HealthCare (Germany)
•             Astellas Pharma/Agensys (Japan)
•             Progenics Pharmaceuticals (US)
•             Mersana Therapeutics (US)
•             Synthon (US)
•             Heidelberg Pharma (Germany)
•             Oxford BioTherapeutics (US)
•             Others
 
The market revenue and share have been analyzed with respect to the following regions and countries:
 
Americas
North America
•             US
•             Canada
South America
Europe
Western Europe
•             Germany
•             France
•             Italy
•             Spain
•             UK
•             Rest Of Western Europe
Eastern Europe
Asia Pacific
China
India
Japan
Australia
Republic of Korea
Rest of Asia Pacific
The Middle East & Africa
UAE
Saudi Arabia
Egypt
Oman
Kuwait
Qatar
Rest Of Middle East And Africa
 
On the basis of type, the antibody drug conjugate market has been categorized into the following segments:
 
•             Polyvalent Heterologous. Antivenom
•             Monovalent Heterologous. Antivenom
•             Homologous Antivenom
•             Small Molecule Anti-Toxins
 
On the basis of type, the antibody drug conjugate market has been categorized into the following segments:
 
•             Monoclonal Antibodies
•             Linker
•             Drug/Toxin
•             Others
 
On the basis of application, the antibody drug conjugate market has been categorized into the following segments:
 
•             Leukemia
o             Acute Myeloid Leukemia (AML)
o             Chronic Myeloid Leukemia (CML)
o             Acute Lymphocytic Leukemia (ALL)
o             Chronic Lymphocytic Leukemia (CLL)
•             Prostate Cancer
•             Kidney Cancer
•             Pancreas Cancer
•             Ovary Cancer
•             Glioblastoma
•             Lung Cancer
•             Colon Cancer
•             Breast Cancer
•             Skin Cancer
•             Solid Tumors
•             Multiple Myeloma
•             Lymphoma
•             Others
 
On the basis of product, the antibody drug conjugate market has been categorized into the following segments:
 
•             Adcertis
•             Kadcyla
•             Others
 
On the basis of technology, the antibody drug conjugate market has been categorized into the following segments:
 
•             ImmunoGen Technology
•             Seattle Genetics Technology
•             Immunomedics Technology
•             Others
 
On the basis of end-user, the antibody drug conjugate market has been categorized into the following segments:
•             Hospitals
•             Specialized Cancer Centers
•             Academic Research Institutes
•             Biopharmaceutical Companies
•             Others
 
Research Methodology
Analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data.
 
Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Antibody Drug Conjugate Market, By Type
Chapter 7. Global Antibody Drug Conjugate Market, By Application
…Continued                             
 
ACCESS REPORT @  https://www.wiseguyreports.com/reports/3365852-antibody-drug-conjugate-market-research-report-forecast-to-2023
                                        
Contact Info:                                                         
NORAH TRENT                                                      
sales@wiseguyreports.com             
Ph: +1-646-845-9349 (US)                         
Ph: +44 208 133 9349 (UK)                                                 
                                                                             
Get in touch:                                                          
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports                                                                  
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts